🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this first-in-human study is to evaluate the safety, pharmac...
Status
Completed
Location
Opthea Investigative Site
Start Date
2015-07
Trial ID
NCT02543229
Central and branch retinal vein occlusions are major causes of visual loss....
Status
Completed
Location
Wilmer Eye Institute
Start Date
2006-01
Trial ID
NCT00407355
Treatments Being Tested
The purpose of this study is to determine the effect of ranibizumab for the...
Status
Terminated
Location
Seoul National University Bundang Hospital
Start Date
2013-01
Trial ID
NCT01795209
Treatments Being Tested
This study investigates the use of a high dose anti-VEGF agent for the trea...
Status
Completed
Location
The New York Eye Cancer Center
Start Date
2011-05
Trial ID
NCT01334879
Treatments Being Tested
To evaluate and compare two individualised ranibizumab treatment regimens, ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-10-31
Trial ID
NCT01972789
Treatments Being Tested
The objective of this study is to assess the safety and tolerability of top...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02022540
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of differ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-01
Trial ID
NCT01134055
Treatments Being Tested
The primary objectives of this study were to evaluate the safety and effica...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-05-24
Trial ID
NCT03927690
This study will evaluate the effect of combination therapy with verteporfin...
Status
Terminated
Location
Novartis Investigative site
Start Date
2007-05
Trial ID
NCT00433017
Treatments Being Tested
Intravitreal ranibizumab alone was Compared to adding dexamethasone to rani...
Status
Completed
Location
Khaled G Abueleinen
Start Date
2020-07-01
Trial ID
NCT05271539
Treatments Being Tested